Vincent Trebosc

98 posts

Vincent Trebosc banner
Vincent Trebosc

Vincent Trebosc

@V_Trebosc

Microbiologist interested in drug discovery, AMR, virulence and synthetic biology (and wine and rugby and..) 🇨🇵🇨🇭

Katılım Aralık 2016
401 Takip Edilen125 Takipçiler
Vincent Trebosc retweetledi
David Grainger
David Grainger@GraingerLab·
Well done @mulecc - your PhD work just published 😀nature.com/articles/s4146… I think we've only scratched the surface with this... H-NS allowing bacteria to direct their own evolution. Exciting times ahead...
English
5
34
132
13K
Vincent Trebosc retweetledi
Hirsch Lab
Hirsch Lab@HirschLab·
We are seeking excellent candidates for three PostDoc positions at the Department of Drug Design and Optimization, HIPS. If you have a strong background in MedChem and synthesis of bioactive small molecules, then feel free to apply! helmholtz-hzi.de/en/career/jobs…
English
2
28
59
13.5K
Vincent Trebosc retweetledi
ASM
ASM@ASMicrobiology·
Bacteria often adapt to stress through 2-component regulatory systems (TCS). In Klebsiella pneumoniae, the EnvZ/OmpR TCS facilitates lung infection by transcriptionally regulating key virulence factors. Read the article in @JournalSpectrum: asm.social/1Ei
ASM tweet media
English
0
25
66
10.1K
Vincent Trebosc retweetledi
Nature Microbiology
Nature Microbiology@NatureMicrobiol·
Out now! In vitro models that mimic within patient conditions should be used to revitalize antibiotic discovery and development nature.com/articles/s4156…
English
2
38
122
32.2K
Vincent Trebosc retweetledi
Francois Lebreton
Francois Lebreton@Fr_Lebreton·
If you are like me and do everything at the last minute, now is the time to apply to #AMR ICARe course (Oct 7-15). Full program is available at icarecourse.org and deadline for student application is June 21! @sylvainbrisse and I will teach genomic epi + hands on bioinf
Francois Lebreton tweet media
English
1
8
24
4.8K
Vincent Trebosc retweetledi
Centre d'infection et d'immunité de Lille
👇Check it out: a call for a Junior Group Leader on Infectious diseases and/or antimicrobial resistance Institut Pasteur de Lille, France
Centre d'infection et d'immunité de Lille tweet mediaCentre d'infection et d'immunité de Lille tweet media
English
0
14
21
6.7K
Vincent Trebosc retweetledi
Pierre Jacquel
Pierre Jacquel@pierre_jacquel2·
Rappel pour nos amis chercheurs et étudiants : il est INTERDIT d'utiliser ce site qui permet d'accéder à tous les articles de recherche gratuitement ! Ce site est souvent bloqué par les fournisseurs internet, il est aussi interdit de contourner le blocage avec cette méthode. 🧵
Pierre Jacquel tweet media
Français
472
10.7K
29.9K
3.3M
Vincent Trebosc retweetledi
AMR Action Fund
AMR Action Fund@AMRActionFund·
"In just about every other therapeutic area, investors and drugmakers can rely on the market to reward the development of impactful medicines through strong sales," writes @deepalimpatel. "Not so with antimicrobials." #AMR efpia.eu/news-events/th… via @EFPIA
AMR Action Fund tweet media
English
0
15
20
5.6K
Vincent Trebosc retweetledi
Valeria Gigante
Valeria Gigante@valeria_gigante·
⏰Consultancy opportunity to work on the antibacterial pipeline review. Closing tomorrow! Please share in your network! @HatimSati @WHO
Valeria Gigante@valeria_gigante

📨Consultancy opportunity in my team at @WHO 🔎We are looking for a junior figure (>3 years of experience) to support the WHO annual antibacterial pipeline review. ➡️Closing Date: 3 April 2023, Link below👇 careers.who.int/careersection/…

English
1
11
11
2.3K
Vincent Trebosc retweetledi
ANTIBIOTIC CellMAP
ANTIBIOTIC CellMAP@TRR261·
TRR261 announces and recommends the ICARe 2023 course!
ANTIBIOTIC CellMAP tweet media
English
0
7
18
1.7K
Vincent Trebosc retweetledi
AMR Action Fund
AMR Action Fund@AMRActionFund·
“I personally find it unacceptable that we would have drugs in hand that help a significant number of patients from not passing away — and we have to drop this for financial reasons, rather than scientific ones.” The unfortunate reality of the abx market ft.com/content/2730bf…
English
0
6
15
1.6K
Vincent Trebosc retweetledi
BioVersys
BioVersys@Bioversys·
#BioVersys is delighted to announce the 1st patient dosed in Phase 2a clinical trial with BVL-GSK098. The trial is being run in South Africa with our partners @taskapplied, and in collaboration with @GSK. This study receives valuable funding from @EDCTP. lnkd.in/e34Ty-65
BioVersys tweet media
English
0
8
19
5.8K
Vincent Trebosc retweetledi
AMR Action Fund
AMR Action Fund@AMRActionFund·
We are thrilled to announce our investment into @BioVersys! The antibiotics they are developing target some of the highest-priority drug-resistant pathogens and could deliver significant benefits to patients suffering from life-threatening infections. amractionfund.com/blog-2022/amr-… #AMR
AMR Action Fund tweet media
English
1
11
35
17.8K